Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Robert Brett McQueen"'
Autor:
Robert Brett McQueen, Mark Gritz, Drew Kern, Julienne L. Bemski, Ian Shelton, Martha Meyer, Benzi M. Kluger
Publikováno v:
Neurology: Clinical Practice. 12:429-437
Implementation of palliative care (PC) in neurology settings may improve symptom control and quality of life and reduce acute care admissions. The benefits of team-based PC for patients with Parkinson disease have been established through rigorous ev
Autor:
Nicholas D Mendola, Elisabeth Oehrlein, Eleanor M Perfetto, Kimberly Westrich, Robert Brett McQueen
Publikováno v:
Journal of managed carespecialty pharmacy. 28(10)
Autor:
Janis M. Miyasaki, Elizabeth R Goy, Miriam J. Johnson, Jean S. Kutner, Umer Akbar, Benzi M. Kluger, Julie H. Carter, Robert Brett McQueen, Julienne Bemski
Publikováno v:
Journal of Neurology, Neurosurgery, and Psychiatry
Parkinson’s disease and related disorders (PDRD) are the second most common neurodegenerative disease and a leading cause of death. However, patients with PDRD receive less end-of-life palliative care (hospice) than other illnesses, including other
Autor:
Elaine J Scallan Walter, Satvinder K. Dhaliwal, Sandra Hoffmann, Jae-Wan Ahn, Alice E White, Robert Brett McQueen
Publikováno v:
Foodborne pathogens and disease. 18(11)
Foodborne illness is a continuing public health problem in the United States. Seven pathogens—Campylobacter, Clostridium perfringens, Shiga toxin–producing Escherichia coli O157, Listeria monocytog...
Publikováno v:
Medical Care. 55:909-911
The Second Panel on Cost-Effectiveness in Health and Medicine convened on December 7, 2016 at the National Academy of Medicine to disseminate their recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses (C
Publikováno v:
Medical Care. 55:915-917
The Second Panel on Cost-Effectiveness in Health and Medicine recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses has a number of questions unanswered with respect to the implementation of transparent,
Autor:
Robert Brett McQueen, Garth Wright, Ellen L. Burnham, Edward T. Van Matre, Pei Jai Michael Ho, Robert William Vandivier, Marc Moss, Paul M. Reynolds, Tyree H. Kiser
Publikováno v:
Pharmacotherapy. 39(3)
BACKGROUND Venous thromboembolism (VTE) occurs frequently in critically ill patients without heparin prophylaxis. Although heparin prevents VTE, VTEs occur frequently despite prophylaxis. A higher heparin dosage may be more effective for preventing V
Autor:
Jonathan D. Campbell, M. Ott, Hayden Holmes, Melanie D Whittington, Joyce Craig, Marc D. Breton, Robert Brett McQueen
Publikováno v:
Journal of diabetes science and technology. 12(5)
Objective:The objective was to model clinical and economic outcomes of self-monitoring blood glucose (SMBG) devices with varying error ranges and strip prices for type 1 and insulin-treated type 2 diabetes patients in England.Methods:We programmed a
Publikováno v:
International Journal of Technology Assessment in Health Care. 33:208-209
INTRODUCTION:A common approach to one-way sensitivity analysis is to vary inputs by a constant percentage. An alternative is to derive ranges using evidence-based probability distributions from published sources. Our objective was to compare one-way
Autor:
Richard R. Allen, Homa B. Dastani, Vahram Ghushcyan, Jacci Bainbridge, John R. Corboy, Kristijan H. Kahler, Nikita Mody-Patel, Kavita V. Nair, Robert Brett McQueen
Publikováno v:
Expert Review of Neurotherapeutics. 11:787-798
We examined the use of 23 diagnostic procedures and monitoring tests for users of disease-modifying therapy (DMT) and non-DMT users with multiple sclerosis (MS). The Medstat MarketScan(®) Commercial Claims and Encounters database (2003-2007), which